药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Maprotiline
Epitizide
Epitizide may increase the excretion rate of Valganciclovir which could result in a lower serum level and potentially a reduction in efficacy.
Maprotiline
Xipamide
Xipamide may increase the excretion rate of Valganciclovir which could result in a lower serum level and potentially a reduction in efficacy.
Maprotiline
Muzolimine
Muzolimine may increase the excretion rate of Valganciclovir which could result in a lower serum level and potentially a reduction in efficacy.
Maprotiline
Clopamide
Clopamide may increase the excretion rate of Valganciclovir which could result in a lower serum level and potentially a reduction in efficacy.
Maprotiline
Fenquizone
Fenquizone may increase the excretion rate of Valganciclovir which could result in a lower serum level and potentially a reduction in efficacy.
Maprotiline
Clofenamide
Clofenamide may increase the excretion rate of Valganciclovir which could result in a lower serum level and potentially a reduction in efficacy.
Maprotiline
Clorexolone
Clorexolone may increase the excretion rate of Valganciclovir which could result in a lower serum level and potentially a reduction in efficacy.
Maprotiline
Cyclopenthiazide
Cyclopenthiazide may increase the excretion rate of Valganciclovir which could result in a lower serum level and potentially a reduction in efficacy.
Maprotiline
Mebutizide
Mebutizide may increase the excretion rate of Valganciclovir which could result in a lower serum level and potentially a reduction in efficacy.
Maprotiline
Mefruside
Mefruside may increase the excretion rate of Valganciclovir which could result in a lower serum level and potentially a reduction in efficacy.
Maprotiline
Meticrane
Meticrane may increase the excretion rate of Valganciclovir which could result in a lower serum level and potentially a reduction in efficacy.
Maprotiline
Cicletanine
Cicletanine may increase the excretion rate of Valganciclovir which could result in a lower serum level and potentially a reduction in efficacy.
Maprotiline
Spiradoline
Spiradoline may increase the excretion rate of Valganciclovir which could result in a lower serum level and potentially a reduction in efficacy.
Maprotiline
Rolofylline
Rolofylline may increase the excretion rate of Valganciclovir which could result in a lower serum level and potentially a reduction in efficacy.
Maprotiline
Canrenone
Canrenone may increase the excretion rate of Valganciclovir which could result in a lower serum level and potentially a reduction in efficacy.
Maprotiline
Ertugliflozin
Ertugliflozin may increase the excretion rate of Valganciclovir which could result in a lower serum level and potentially a reduction in efficacy.
Maprotiline
Isosorbide
Isosorbide may increase the excretion rate of Valganciclovir which could result in a lower serum level and potentially a reduction in efficacy.
Maprotiline
Efonidipine
Efonidipine may increase the excretion rate of Valganciclovir which could result in a lower serum level and potentially a reduction in efficacy.
Maprotiline
Potassium citrate
Potassium citrate may increase the excretion rate of Valganciclovir which could result in a lower serum level and potentially a reduction in efficacy.
Maprotiline
Canrenoic acid
Canrenoic acid may increase the excretion rate of Valganciclovir which could result in a lower serum level and potentially a reduction in efficacy.